November 14, 2007 -- For a change, a China-based biopharma released a Q3 financial report that made investors happy, sending them out to buy the stock and push its price higher. 3SBio (NSDQ: SSRX) reported revenues that climbed 57% and profits that jumped a large 151%. The shares of 3SBio responded by gaining 16% in the first post-report session. We look at the numbers. More details...
